| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | sodium ion binding | 2.27e-09 | 14 | 84 | 5 | GO:0031402 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 7.17e-08 | 26 | 84 | 5 | GO:0005248 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 7.17e-08 | 26 | 84 | 5 | GO:0031420 | |
| GeneOntologyMolecularFunction | sodium channel activity | 2.60e-06 | 52 | 84 | 5 | GO:0005272 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 4.68e-05 | 17 | 84 | 3 | GO:0099508 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 1.04e-04 | 4 | 84 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 1.46e-04 | 465 | 84 | 9 | GO:0046873 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | DOCK5 FRY TBC1D15 PPP2R3A PTPA PDE8A CAPN3 PPME1 ITPRIP C4A C4B APOA4 OCRL ADGRV1 SERPINA6 ARAP2 | 2.45e-04 | 1418 | 84 | 16 | GO:0030234 |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 2.59e-04 | 6 | 84 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 4.24e-04 | 323 | 84 | 7 | GO:1901681 | |
| GeneOntologyMolecularFunction | acetylgalactosaminyltransferase activity | 4.26e-04 | 35 | 84 | 3 | GO:0008376 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 6.06e-04 | 343 | 84 | 7 | GO:0005261 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 6.94e-04 | 459 | 84 | 8 | GO:0005216 | |
| GeneOntologyMolecularFunction | complement component C1q complex binding | 7.70e-04 | 10 | 84 | 2 | GO:0001849 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 7.77e-04 | 171 | 84 | 5 | GO:0015081 | |
| GeneOntologyMolecularFunction | phosphoric ester hydrolase activity | 1.21e-03 | 386 | 84 | 7 | GO:0042578 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 1.27e-03 | 627 | 84 | 9 | GO:0022890 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 1.28e-03 | 758 | 84 | 10 | GO:0015318 | |
| GeneOntologyMolecularFunction | cytidine deaminase activity | 1.32e-03 | 13 | 84 | 2 | GO:0004126 | |
| GeneOntologyMolecularFunction | channel activity | 1.64e-03 | 525 | 84 | 8 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 1.66e-03 | 526 | 84 | 8 | GO:0022803 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 1.79e-03 | 793 | 84 | 10 | GO:0015075 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 1.88e-03 | 664 | 84 | 9 | GO:0008324 | |
| GeneOntologyMolecularFunction | carbohydrate binding | 1.97e-03 | 310 | 84 | 6 | GO:0030246 | |
| GeneOntologyMolecularFunction | calcium-dependent cysteine-type endopeptidase activity | 2.28e-03 | 17 | 84 | 2 | GO:0004198 | |
| GeneOntologyMolecularFunction | enzyme inhibitor activity | 2.38e-03 | 435 | 84 | 7 | GO:0004857 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 2.56e-03 | 18 | 84 | 2 | GO:0015278 | |
| GeneOntologyMolecularFunction | gated channel activity | 2.85e-03 | 334 | 84 | 6 | GO:0022836 | |
| GeneOntologyMolecularFunction | polypeptide N-acetylgalactosaminyltransferase activity | 3.16e-03 | 20 | 84 | 2 | GO:0004653 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 3.80e-03 | 151 | 84 | 4 | GO:0015085 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-AMP phosphodiesterase activity | 3.82e-03 | 22 | 84 | 2 | GO:0004115 | |
| GeneOntologyMolecularFunction | calcium ion binding | 4.19e-03 | 749 | 84 | 9 | GO:0005509 | |
| GeneOntologyMolecularFunction | copper ion binding | 4.35e-03 | 78 | 84 | 3 | GO:0005507 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-GMP phosphodiesterase activity | 4.54e-03 | 24 | 84 | 2 | GO:0047555 | |
| GeneOntologyMolecularFunction | collagen binding | 4.84e-03 | 81 | 84 | 3 | GO:0005518 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-nucleotide phosphodiesterase activity | 4.93e-03 | 25 | 84 | 2 | GO:0004114 | |
| GeneOntologyMolecularFunction | opsonin binding | 4.93e-03 | 25 | 84 | 2 | GO:0001846 | |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase activity | 5.72e-03 | 86 | 84 | 3 | GO:0004197 | |
| GeneOntologyMolecularFunction | cyclic-nucleotide phosphodiesterase activity | 5.73e-03 | 27 | 84 | 2 | GO:0004112 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 5.95e-08 | 87 | 83 | 7 | GO:0086001 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 9.47e-08 | 93 | 83 | 7 | GO:0086003 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 1.81e-07 | 62 | 83 | 6 | GO:0086002 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 2.24e-07 | 217 | 83 | 9 | GO:0006941 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 3.19e-07 | 36 | 83 | 5 | GO:0086010 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 8.00e-07 | 127 | 83 | 7 | GO:0070252 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 2.79e-06 | 153 | 83 | 7 | GO:0030048 | |
| GeneOntologyBiologicalProcess | muscle contraction | 4.64e-06 | 400 | 83 | 10 | GO:0006936 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 4.98e-06 | 167 | 83 | 7 | GO:0060048 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 5.47e-06 | 63 | 83 | 5 | GO:0019228 | |
| GeneOntologyBiologicalProcess | muscle system process | DOCK5 SCN1A SCN2A SCN3A SCN9A SCN10A ATP2A2 RYR1 RYR2 SMAD4 CHUK | 1.19e-05 | 547 | 83 | 11 | GO:0003012 |
| GeneOntologyBiologicalProcess | action potential | 1.67e-05 | 201 | 83 | 7 | GO:0001508 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception of pain | 2.67e-05 | 43 | 83 | 4 | GO:0062149 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus involved in sensory perception | 8.19e-05 | 57 | 83 | 4 | GO:0050974 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 8.94e-05 | 112 | 83 | 5 | GO:0019226 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 1.29e-04 | 121 | 83 | 5 | GO:0051899 | |
| GeneOntologyBiologicalProcess | detection of temperature stimulus involved in sensory perception of pain | 1.53e-04 | 26 | 83 | 3 | GO:0050965 | |
| GeneOntologyBiologicalProcess | multicellular organismal response to stress | 1.56e-04 | 126 | 83 | 5 | GO:0033555 | |
| GeneOntologyBiologicalProcess | heart contraction | 1.99e-04 | 298 | 83 | 7 | GO:0060047 | |
| GeneOntologyBiologicalProcess | detection of temperature stimulus involved in sensory perception | 2.36e-04 | 30 | 83 | 3 | GO:0050961 | |
| GeneOntologyBiologicalProcess | clearance of foreign intracellular DNA | 2.37e-04 | 6 | 83 | 2 | GO:0044355 | |
| GeneOntologyBiologicalProcess | clearance of foreign intracellular nucleic acids | 2.37e-04 | 6 | 83 | 2 | GO:0099046 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus | 2.38e-04 | 75 | 83 | 4 | GO:0050982 | |
| GeneOntologyBiologicalProcess | heart process | 2.48e-04 | 309 | 83 | 7 | GO:0003015 | |
| GeneOntologyBiologicalProcess | muscle cell differentiation | 2.81e-04 | 531 | 83 | 9 | GO:0042692 | |
| GeneOntologyBiologicalProcess | behavioral response to pain | 2.86e-04 | 32 | 83 | 3 | GO:0048266 | |
| GeneOntologyBiologicalProcess | response to abiotic stimulus | DPP4 PDE8B SCN1A SCN2A CAPN3 SCN9A SCN10A HRH1 PRDM12 FGFR2 ADGRV1 RYR1 RYR2 SMAD4 CHUK | 3.13e-04 | 1361 | 83 | 15 | GO:0009628 |
| GeneOntologyBiologicalProcess | detection of temperature stimulus | 3.14e-04 | 33 | 83 | 3 | GO:0016048 | |
| GeneOntologyBiologicalProcess | left ventricular cardiac muscle tissue morphogenesis | 3.32e-04 | 7 | 83 | 2 | GO:0003220 | |
| GeneOntologyBiologicalProcess | regulation of extracellular matrix organization | 3.68e-04 | 84 | 83 | 4 | GO:1903053 | |
| GeneOntologyBiologicalProcess | positive regulation of apoptotic cell clearance | 4.41e-04 | 8 | 83 | 2 | GO:2000427 | |
| GeneOntologyBiologicalProcess | sensory perception of temperature stimulus | 4.79e-04 | 38 | 83 | 3 | GO:0050951 | |
| GeneOntologyBiologicalProcess | response to mechanical stimulus | 4.85e-04 | 247 | 83 | 6 | GO:0009612 | |
| GeneOntologyBiologicalProcess | cAMP catabolic process | 5.65e-04 | 9 | 83 | 2 | GO:0006198 | |
| GeneOntologyBiologicalProcess | regulation of lipase activity | 6.00e-04 | 41 | 83 | 3 | GO:0060191 | |
| GeneOntologyBiologicalProcess | muscle structure development | DOCK5 PPP2R3A FKTN CAPN3 ATP11A FGFR2 ATP2A2 RYR1 RYR2 SMAD4 CHUK | 6.34e-04 | 858 | 83 | 11 | GO:0061061 |
| GeneOntologyBiologicalProcess | detection of external stimulus | 6.71e-04 | 173 | 83 | 5 | GO:0009581 | |
| GeneOntologyBiologicalProcess | DNA cytosine deamination | 7.05e-04 | 10 | 83 | 2 | GO:0070383 | |
| GeneOntologyBiologicalProcess | protein O-linked glycosylation via serine | 7.05e-04 | 10 | 83 | 2 | GO:0018242 | |
| GeneOntologyBiologicalProcess | protein O-linked glycosylation via threonine | 7.05e-04 | 10 | 83 | 2 | GO:0018243 | |
| GeneOntologyBiologicalProcess | regulation of apoptotic cell clearance | 7.05e-04 | 10 | 83 | 2 | GO:2000425 | |
| GeneOntologyBiologicalProcess | detection of abiotic stimulus | 7.07e-04 | 175 | 83 | 5 | GO:0009582 | |
| GeneOntologyBiologicalProcess | circulatory system process | 7.08e-04 | 733 | 83 | 10 | GO:0003013 | |
| GeneOntologyBiologicalProcess | sarcoplasmic reticulum calcium ion transport | 7.39e-04 | 44 | 83 | 3 | GO:0070296 | |
| GeneOntologyBiologicalProcess | steroid metabolic process | 8.00e-04 | 376 | 83 | 7 | GO:0008202 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 8.13e-04 | 377 | 83 | 7 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 8.26e-04 | 378 | 83 | 7 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 8.38e-04 | 379 | 83 | 7 | GO:0045229 | |
| GeneOntologyBiologicalProcess | sensory perception of pain | 8.56e-04 | 105 | 83 | 4 | GO:0019233 | |
| GeneOntologyBiologicalProcess | cellular response to caffeine | 8.59e-04 | 11 | 83 | 2 | GO:0071313 | |
| GeneOntologyBiologicalProcess | apoptotic cell clearance | 9.54e-04 | 48 | 83 | 3 | GO:0043277 | |
| GeneOntologyBiologicalProcess | striated muscle cell differentiation | 1.01e-03 | 391 | 83 | 7 | GO:0051146 | |
| GeneOntologyBiologicalProcess | cytidine to uridine editing | 1.03e-03 | 12 | 83 | 2 | GO:0016554 | |
| GeneOntologyBiologicalProcess | AV node cell to bundle of His cell signaling | 1.03e-03 | 12 | 83 | 2 | GO:0086027 | |
| GeneOntologyBiologicalProcess | AV node cell action potential | 1.03e-03 | 12 | 83 | 2 | GO:0086016 | |
| GeneOntologyBiologicalProcess | manganese ion transmembrane transport | 1.03e-03 | 12 | 83 | 2 | GO:0071421 | |
| GeneOntologyBiologicalProcess | actin filament-based process | SCN1A SCN2A SCN3A CAPN3 SCN9A SCN10A LRP1 ATP2A2 TNXB RYR2 SMAD4 | 1.04e-03 | 912 | 83 | 11 | GO:0030029 |
| GeneOntologyBiologicalProcess | response to toxic substance | 1.10e-03 | 289 | 83 | 6 | GO:0009636 | |
| GeneOntologyBiologicalProcess | response to pain | 1.14e-03 | 51 | 83 | 3 | GO:0048265 | |
| GeneOntologyBiologicalProcess | blood circulation | 1.17e-03 | 648 | 83 | 9 | GO:0008015 | |
| GeneOntologyBiologicalProcess | regulation of muscle contraction | 1.34e-03 | 202 | 83 | 5 | GO:0006937 | |
| GeneOntologyBiologicalProcess | cytidine catabolic process | 1.41e-03 | 14 | 83 | 2 | GO:0006216 | |
| GeneOntologyBiologicalProcess | cyclic nucleotide catabolic process | 1.41e-03 | 14 | 83 | 2 | GO:0009214 | |
| GeneOntologyBiologicalProcess | DNA deamination | 1.41e-03 | 14 | 83 | 2 | GO:0045006 | |
| GeneOntologyBiologicalProcess | manganese ion transport | 1.41e-03 | 14 | 83 | 2 | GO:0006828 | |
| GeneOntologyBiologicalProcess | cytidine metabolic process | 1.41e-03 | 14 | 83 | 2 | GO:0046087 | |
| GeneOntologyBiologicalProcess | cytidine deamination | 1.41e-03 | 14 | 83 | 2 | GO:0009972 | |
| GeneOntologyBiologicalProcess | cellular response to purine-containing compound | 1.41e-03 | 14 | 83 | 2 | GO:0071415 | |
| GeneOntologyBiologicalProcess | response to metal ion | 1.42e-03 | 415 | 83 | 7 | GO:0010038 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 1.53e-03 | 208 | 83 | 5 | GO:0035725 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 4.89e-09 | 17 | 82 | 5 | GO:0001518 | |
| GeneOntologyCellularComponent | sodium channel complex | 9.05e-08 | 29 | 82 | 5 | GO:0034706 | |
| GeneOntologyCellularComponent | cation channel complex | 3.95e-06 | 235 | 82 | 8 | GO:0034703 | |
| GeneOntologyCellularComponent | transporter complex | PTPA SCN1A SCN2A SCN3A SCN9A SCN10A ATP11A ATP2A2 RYR1 RYR2 GABRA6 | 9.79e-06 | 550 | 82 | 11 | GO:1990351 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 1.72e-05 | 378 | 82 | 9 | GO:0034702 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 3.75e-05 | 523 | 82 | 10 | GO:1902495 | |
| GeneOntologyCellularComponent | stereocilium membrane | 2.26e-04 | 6 | 82 | 2 | GO:0060171 | |
| GeneOntologyCellularComponent | T-tubule | 2.64e-04 | 79 | 82 | 4 | GO:0030315 | |
| GeneOntologyCellularComponent | symbiont cell surface | 4.19e-04 | 8 | 82 | 2 | GO:0106139 | |
| GeneOntologyCellularComponent | other organism part | 5.38e-04 | 9 | 82 | 2 | GO:0044217 | |
| GeneOntologyCellularComponent | junctional sarcoplasmic reticulum membrane | 6.70e-04 | 10 | 82 | 2 | GO:0014701 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 7.33e-04 | 45 | 82 | 3 | GO:0033017 | |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 8.09e-04 | 185 | 82 | 5 | GO:0009898 | |
| GeneOntologyCellularComponent | sarcolemma | 9.12e-04 | 190 | 82 | 5 | GO:0042383 | |
| GeneOntologyCellularComponent | sarcoplasm | 1.06e-03 | 114 | 82 | 4 | GO:0016528 | |
| GeneOntologyCellularComponent | phosphatase complex | 1.32e-03 | 55 | 82 | 3 | GO:1903293 | |
| GeneOntologyCellularComponent | protein serine/threonine phosphatase complex | 1.32e-03 | 55 | 82 | 3 | GO:0008287 | |
| GeneOntologyCellularComponent | extrinsic component of cytoplasmic side of plasma membrane | 1.39e-03 | 56 | 82 | 3 | GO:0031234 | |
| GeneOntologyCellularComponent | membrane protein complex | PTPA IGF2R SCN1A SCN2A SCN3A SCN9A SCN10A LRP1 CTDNEP1 ATP2A2 RYR1 RYR2 CHUK GABRA6 | 1.95e-03 | 1498 | 82 | 14 | GO:0098796 |
| GeneOntologyCellularComponent | cytoplasmic side of membrane | 2.12e-03 | 230 | 82 | 5 | GO:0098562 | |
| GeneOntologyCellularComponent | protein phosphatase type 2A complex | 2.23e-03 | 18 | 82 | 2 | GO:0000159 | |
| GeneOntologyCellularComponent | intercalated disc | 2.43e-03 | 68 | 82 | 3 | GO:0014704 | |
| GeneOntologyCellularComponent | blood microparticle | 2.49e-03 | 144 | 82 | 4 | GO:0072562 | |
| GeneOntologyCellularComponent | axon | 2.50e-03 | 891 | 82 | 10 | GO:0030424 | |
| GeneOntologyCellularComponent | node of Ranvier | 2.76e-03 | 20 | 82 | 2 | GO:0033268 | |
| GeneOntologyCellularComponent | Z disc | 2.96e-03 | 151 | 82 | 4 | GO:0030018 | |
| GeneOntologyCellularComponent | calcium channel complex | 2.97e-03 | 73 | 82 | 3 | GO:0034704 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | IGF2R GALNT1 PDE8A PDE8B LRP1 ADGRV1 SRCAP ATP2A2 GALNT4 RYR1 | 3.51e-03 | 934 | 82 | 10 | GO:0048471 |
| GeneOntologyCellularComponent | neuron projection membrane | 4.12e-03 | 82 | 82 | 3 | GO:0032589 | |
| GeneOntologyCellularComponent | I band | 4.15e-03 | 166 | 82 | 4 | GO:0031674 | |
| GeneOntologyCellularComponent | presynaptic membrane | 4.69e-03 | 277 | 82 | 5 | GO:0042734 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 5.02e-03 | 88 | 82 | 3 | GO:0016529 | |
| HumanPheno | Generalized cerebral atrophy/hypoplasia | 2.45e-06 | 13 | 41 | 4 | HP:0007058 | |
| HumanPheno | Atypical absence status epilepticus | 7.97e-06 | 17 | 41 | 4 | HP:0011151 | |
| HumanPheno | Generalized non-convulsive status epilepticus without coma | 1.02e-05 | 18 | 41 | 4 | HP:0032860 | |
| HumanPheno | Non-convulsive status epilepticus without coma | 1.59e-05 | 20 | 41 | 4 | HP:0032671 | |
| HumanPheno | Talipes valgus | 1.96e-05 | 21 | 41 | 4 | HP:0004684 | |
| HumanPheno | Photosensitive myoclonic seizure | 2.64e-05 | 8 | 41 | 3 | HP:0001327 | |
| HumanPheno | Cyanotic episode | 2.64e-05 | 8 | 41 | 3 | HP:0200048 | |
| HumanPheno | Tibial torsion | 2.86e-05 | 23 | 41 | 4 | HP:0100694 | |
| HumanPheno | Rigidity | 3.73e-05 | 214 | 41 | 9 | HP:0002063 | |
| HumanPheno | Limited knee extension | 5.55e-05 | 27 | 41 | 4 | HP:0003066 | |
| HumanPheno | Status epilepticus without prominent motor symptoms | 5.55e-05 | 27 | 41 | 4 | HP:0031475 | |
| HumanPheno | Limited neck range of motion | 7.64e-05 | 11 | 41 | 3 | HP:0000466 | |
| HumanPheno | Epilepsia partialis continua | 1.01e-04 | 12 | 41 | 3 | HP:0012847 | |
| HumanPheno | Cogwheel rigidity | 1.10e-04 | 32 | 41 | 4 | HP:0002396 | |
| HumanPheno | Obsessive-compulsive trait | 1.25e-04 | 33 | 41 | 4 | HP:0008770 | |
| HumanPheno | Abnormal ankle morphology | 1.27e-04 | 100 | 41 | 6 | HP:0034673 | |
| HumanPheno | Calcaneovalgus deformity | 1.41e-04 | 34 | 41 | 4 | HP:0001848 | |
| HumanPheno | Deformed tarsal bones | 1.58e-04 | 35 | 41 | 4 | HP:0008119 | |
| HumanPheno | Limitation of knee mobility | 1.58e-04 | 35 | 41 | 4 | HP:0010501 | |
| HumanPheno | Disturbance of facial expression | 1.77e-04 | 36 | 41 | 4 | HP:0005324 | |
| HumanPheno | Scapular muscle atrophy | 1.89e-04 | 3 | 41 | 2 | HP:0009060 | |
| HumanPheno | Facial tics | 2.06e-04 | 15 | 41 | 3 | HP:0011468 | |
| HumanPheno | Photosensitive tonic-clonic seizure | 2.06e-04 | 15 | 41 | 3 | HP:0007207 | |
| HumanPheno | Dysgenesis of the hippocampus | 2.52e-04 | 16 | 41 | 3 | HP:0025101 | |
| HumanPheno | Complex febrile seizure | 2.52e-04 | 16 | 41 | 3 | HP:0011172 | |
| HumanPheno | Bradykinesia | 2.87e-04 | 116 | 41 | 6 | HP:0002067 | |
| HumanPheno | Focal motor status epilepticus | 3.04e-04 | 17 | 41 | 3 | HP:0032663 | |
| HumanPheno | Visually-induced seizure | 3.63e-04 | 18 | 41 | 3 | HP:0020216 | |
| HumanPheno | Amyotrophy involving the shoulder musculature | 3.75e-04 | 4 | 41 | 2 | HP:0001465 | |
| HumanPheno | Limitation of joint mobility | SCN1A HS2ST1 SCN2A CAPN3 SCN9A FGFR2 OCRL ADGRV1 F8 RYR1 SMAD4 | 4.36e-04 | 432 | 41 | 11 | HP:0001376 |
| HumanPheno | Atypical absence seizure | 4.62e-04 | 46 | 41 | 4 | HP:0007270 | |
| MousePheno | increased susceptibility to induced morbidity/mortality | 4.05e-06 | 346 | 65 | 10 | MP:0009763 | |
| MousePheno | translucent skin | 4.20e-05 | 15 | 65 | 3 | MP:0001201 | |
| MousePheno | abnormal susceptibility to induced morbidity/mortality | 5.82e-05 | 471 | 65 | 10 | MP:0020148 | |
| MousePheno | abnormal heart septum morphology | 7.21e-05 | 388 | 65 | 9 | MP:0006113 | |
| MousePheno | abnormal breathing pattern | 7.67e-05 | 303 | 65 | 8 | MP:0001951 | |
| MousePheno | omphalocele | 1.05e-04 | 53 | 65 | 4 | MP:0003052 | |
| MousePheno | decreased paired-pulse ratio | 1.27e-04 | 4 | 65 | 2 | MP:0014253 | |
| MousePheno | abnormal induced morbidity/mortality | DPP4 SCN1A HRH1 C4A C4B ADGRV1 ATP2A2 TNXB F8 RYR1 RYR2 TIPARP | 1.29e-04 | 737 | 65 | 12 | MP:0001657 |
| MousePheno | abnormal parietal endoderm morphology | 1.81e-04 | 24 | 65 | 3 | MP:0011187 | |
| MousePheno | premature bone ossification | 2.31e-04 | 26 | 65 | 3 | MP:0003416 | |
| MousePheno | decreased spleen germinal center number | 2.31e-04 | 26 | 65 | 3 | MP:0008482 | |
| MousePheno | neonatal lethality | CCP110 IGF2R PTPRS SCN1A HS2ST1 SCN9A PRDM12 PPME1 FGFR2 ATP2A2 RYR1 CHUK | 2.73e-04 | 799 | 65 | 12 | MP:0002058 |
| MousePheno | decreased susceptibility to viral infection | 2.84e-04 | 125 | 65 | 5 | MP:0002410 | |
| MousePheno | decreased susceptibility to Coronaviridae infection | 2.89e-04 | 28 | 65 | 3 | MP:0020950 | |
| MousePheno | abnormal Reichert's membrane thickness | 3.16e-04 | 6 | 65 | 2 | MP:0012094 | |
| MousePheno | skeletal muscle degeneration | 3.56e-04 | 30 | 65 | 3 | MP:0009415 | |
| MousePheno | abnormal action potential | 3.78e-04 | 133 | 65 | 5 | MP:0005402 | |
| MousePheno | perinatal lethality, complete penetrance | CCP110 IGF2R HS2ST1 SCN2A SCN9A LRP1 PRDM12 PPME1 FGFR2 RYR1 CHUK | 4.00e-04 | 712 | 65 | 11 | MP:0011089 |
| MousePheno | ventricular fibrillation | 4.40e-04 | 7 | 65 | 2 | MP:0006110 | |
| MousePheno | abnormal paired-pulse ratio | 4.40e-04 | 7 | 65 | 2 | MP:0014252 | |
| MousePheno | abnormal interventricular groove morphology | 4.40e-04 | 7 | 65 | 2 | MP:0004032 | |
| MousePheno | abnormal presphenoid bone morphology | 4.74e-04 | 33 | 65 | 3 | MP:0004448 | |
| MousePheno | thick interventricular septum | 4.74e-04 | 33 | 65 | 3 | MP:0010724 | |
| MousePheno | abnormal respiratory function | 5.00e-04 | 399 | 65 | 8 | MP:0002327 | |
| MousePheno | abnormal abdominal wall morphology | 5.67e-04 | 82 | 65 | 4 | MP:0003257 | |
| MousePheno | perinatal lethality | CCP110 IGF2R PTPRS SCN1A HS2ST1 SCN2A SCN9A LRP1 PRDM12 PPME1 FGFR2 ATP2A2 RYR1 CHUK | 5.73e-04 | 1130 | 65 | 14 | MP:0002081 |
| MousePheno | stomach epithelial hyperplasia | 5.85e-04 | 8 | 65 | 2 | MP:0005493 | |
| Domain | Na_channel_asu | 3.57e-10 | 10 | 82 | 5 | IPR001696 | |
| Domain | Na_trans_assoc | 3.57e-10 | 10 | 82 | 5 | IPR010526 | |
| Domain | Na_trans_assoc | 3.57e-10 | 10 | 82 | 5 | PF06512 | |
| Domain | Na_trans_cytopl | 5.14e-09 | 6 | 82 | 4 | PF11933 | |
| Domain | Na_trans_cytopl | 5.14e-09 | 6 | 82 | 4 | IPR024583 | |
| Domain | Ion_trans_dom | 6.83e-07 | 114 | 82 | 7 | IPR005821 | |
| Domain | Ion_trans | 6.83e-07 | 114 | 82 | 7 | PF00520 | |
| Domain | Channel_four-helix_dom | 5.05e-06 | 57 | 82 | 5 | IPR027359 | |
| Domain | - | 5.05e-06 | 57 | 82 | 5 | 1.20.120.350 | |
| Domain | PDEase_PDE8 | 1.90e-05 | 2 | 82 | 2 | IPR013938 | |
| Domain | IQ_motif_EF-hand-BS | 4.73e-05 | 90 | 82 | 5 | IPR000048 | |
| Domain | IQ | 5.54e-05 | 93 | 82 | 5 | PS50096 | |
| Domain | Ryanrecept_TM4-6 | 5.70e-05 | 3 | 82 | 2 | IPR009460 | |
| Domain | RyR | 5.70e-05 | 3 | 82 | 2 | PF02026 | |
| Domain | Ryanodine_rcpt | 5.70e-05 | 3 | 82 | 2 | IPR003032 | |
| Domain | Cu-oxidase | 5.70e-05 | 3 | 82 | 2 | PF00394 | |
| Domain | RR_TM4-6 | 5.70e-05 | 3 | 82 | 2 | PF06459 | |
| Domain | Ryan_recept | 5.70e-05 | 3 | 82 | 2 | IPR013333 | |
| Domain | Cu-oxidase | 5.70e-05 | 3 | 82 | 2 | IPR001117 | |
| Domain | FAM47 | 1.14e-04 | 4 | 82 | 2 | PF14642 | |
| Domain | Cu-oxidase_2 | 1.14e-04 | 4 | 82 | 2 | IPR011706 | |
| Domain | FAM47 | 1.14e-04 | 4 | 82 | 2 | IPR032743 | |
| Domain | Cu-oxidase_2 | 1.14e-04 | 4 | 82 | 2 | PF07731 | |
| Domain | Cu_oxidase_CS | 1.89e-04 | 5 | 82 | 2 | IPR033138 | |
| Domain | Anaphylatoxin_comp_syst | 1.89e-04 | 5 | 82 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 1.89e-04 | 5 | 82 | 2 | IPR001840 | |
| Domain | Cu-oxidase_3 | 1.89e-04 | 5 | 82 | 2 | IPR011707 | |
| Domain | MULTICOPPER_OXIDASE1 | 1.89e-04 | 5 | 82 | 2 | PS00079 | |
| Domain | Cu-oxidase_3 | 1.89e-04 | 5 | 82 | 2 | PF07732 | |
| Domain | EF-hand-dom_pair | 2.67e-04 | 287 | 82 | 7 | IPR011992 | |
| Domain | IQ | 2.68e-04 | 71 | 82 | 4 | PF00612 | |
| Domain | RIH_assoc | 2.82e-04 | 6 | 82 | 2 | PF08454 | |
| Domain | RIH_assoc-dom | 2.82e-04 | 6 | 82 | 2 | IPR013662 | |
| Domain | RIH_dom | 2.82e-04 | 6 | 82 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 2.82e-04 | 6 | 82 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 2.82e-04 | 6 | 82 | 2 | IPR015925 | |
| Domain | - | 2.82e-04 | 6 | 82 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 2.82e-04 | 6 | 82 | 2 | PF01365 | |
| Domain | Ins145_P3_rec | 2.82e-04 | 6 | 82 | 2 | PF08709 | |
| Domain | Cu_oxidase_Cu_BS | 2.82e-04 | 6 | 82 | 2 | IPR002355 | |
| Domain | ANATO | 3.94e-04 | 7 | 82 | 2 | SM00104 | |
| Domain | ANATO | 3.94e-04 | 7 | 82 | 2 | PF01821 | |
| Domain | ANAPHYLATOXIN_2 | 3.94e-04 | 7 | 82 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 3.94e-04 | 7 | 82 | 2 | PS01177 | |
| Domain | Anaphylatoxin/fibulin | 3.94e-04 | 7 | 82 | 2 | IPR000020 | |
| Domain | EF-hand_8 | 4.42e-04 | 34 | 82 | 3 | PF13833 | |
| Domain | IQ | 4.44e-04 | 81 | 82 | 4 | SM00015 | |
| Domain | Thiol-ester_cl | 5.24e-04 | 8 | 82 | 2 | PF10569 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 5.24e-04 | 8 | 82 | 2 | IPR019565 | |
| Domain | MacrogloblnA2_CS | 5.24e-04 | 8 | 82 | 2 | IPR019742 | |
| Domain | A2M_N | 8.38e-04 | 10 | 82 | 2 | PF01835 | |
| Domain | MIR | 8.38e-04 | 10 | 82 | 2 | PS50919 | |
| Domain | MIR | 8.38e-04 | 10 | 82 | 2 | PF02815 | |
| Domain | MIR | 8.38e-04 | 10 | 82 | 2 | SM00472 | |
| Domain | A2M_N | 8.38e-04 | 10 | 82 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 8.38e-04 | 10 | 82 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 8.38e-04 | 10 | 82 | 2 | PS00477 | |
| Domain | A2M | 8.38e-04 | 10 | 82 | 2 | PF00207 | |
| Domain | MIR_motif | 8.38e-04 | 10 | 82 | 2 | IPR016093 | |
| Domain | A2M_N_2 | 8.38e-04 | 10 | 82 | 2 | IPR011625 | |
| Domain | A2M_comp | 8.38e-04 | 10 | 82 | 2 | IPR011626 | |
| Domain | A2M_N_2 | 8.38e-04 | 10 | 82 | 2 | PF07703 | |
| Domain | A2M_recep | 8.38e-04 | 10 | 82 | 2 | PF07677 | |
| Domain | A2M_comp | 8.38e-04 | 10 | 82 | 2 | PF07678 | |
| Domain | Macroglobln_a2 | 8.38e-04 | 10 | 82 | 2 | IPR001599 | |
| Domain | KRAB | 9.94e-04 | 358 | 82 | 7 | PS50805 | |
| Domain | KRAB | 9.94e-04 | 358 | 82 | 7 | PF01352 | |
| Domain | KRAB | 1.18e-03 | 369 | 82 | 7 | SM00349 | |
| Domain | KRAB | 1.20e-03 | 370 | 82 | 7 | IPR001909 | |
| Domain | APOBEC_N | 1.22e-03 | 12 | 82 | 2 | PF08210 | |
| Domain | Calpain_III | 1.22e-03 | 12 | 82 | 2 | IPR022683 | |
| Domain | calpain_III | 1.22e-03 | 12 | 82 | 2 | SM00720 | |
| Domain | C2_III | 1.22e-03 | 12 | 82 | 2 | IPR033883 | |
| Domain | APOBEC_N | 1.22e-03 | 12 | 82 | 2 | IPR013158 | |
| Domain | Calpain_domain_III | 1.44e-03 | 13 | 82 | 2 | IPR022682 | |
| Domain | Calpain_III | 1.44e-03 | 13 | 82 | 2 | PF01067 | |
| Domain | - | 1.67e-03 | 14 | 82 | 2 | 2.60.40.420 | |
| Domain | Calpain_cysteine_protease | 1.67e-03 | 14 | 82 | 2 | IPR022684 | |
| Domain | APOBEC/CMP_deaminase_Zn-bd | 1.67e-03 | 14 | 82 | 2 | IPR016192 | |
| Domain | CysPc | 1.93e-03 | 15 | 82 | 2 | SM00230 | |
| Domain | Peptidase_C2_calpain_cat | 1.93e-03 | 15 | 82 | 2 | IPR001300 | |
| Domain | Peptidase_C2 | 1.93e-03 | 15 | 82 | 2 | PF00648 | |
| Domain | CALPAIN_CAT | 1.93e-03 | 15 | 82 | 2 | PS50203 | |
| Domain | CYT_DCMP_DEAMINASES_2 | 1.93e-03 | 15 | 82 | 2 | PS51747 | |
| Domain | C345C | 2.48e-03 | 17 | 82 | 2 | SM00643 | |
| Domain | Cytidine_deaminase-like | 2.48e-03 | 17 | 82 | 2 | IPR016193 | |
| Domain | CYT_DCMP_DEAMINASES_1 | 2.48e-03 | 17 | 82 | 2 | PS00903 | |
| Domain | CMP_dCMP_Zn-bd | 2.48e-03 | 17 | 82 | 2 | IPR002125 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 2.78e-03 | 18 | 82 | 2 | IPR008930 | |
| Domain | NTR | 3.10e-03 | 19 | 82 | 2 | PF01759 | |
| Domain | PDEase | 3.10e-03 | 19 | 82 | 2 | IPR023088 | |
| Domain | Netrin_module_non-TIMP | 3.10e-03 | 19 | 82 | 2 | IPR018933 | |
| Domain | PDEase_I | 3.79e-03 | 21 | 82 | 2 | PF00233 | |
| Domain | PDEASE_I | 3.79e-03 | 21 | 82 | 2 | PS00126 | |
| Domain | PDEase_CS | 3.79e-03 | 21 | 82 | 2 | IPR023174 | |
| Domain | Cupredoxin | 4.15e-03 | 22 | 82 | 2 | IPR008972 | |
| Domain | - | 4.15e-03 | 22 | 82 | 2 | 1.10.1300.10 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 1.96e-07 | 130 | 68 | 8 | M27454 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 3.47e-07 | 31 | 68 | 5 | M877 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 4.09e-07 | 32 | 68 | 5 | M27455 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 5.68e-06 | 203 | 68 | 8 | M5485 | |
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 4.36e-13 | 6 | 84 | 5 | 23652591 | |
| Pubmed | 9.11e-12 | 9 | 84 | 5 | 16382098 | ||
| Pubmed | 9.23e-11 | 13 | 84 | 5 | 15123669 | ||
| Pubmed | 1.58e-10 | 5 | 84 | 4 | 8812438 | ||
| Pubmed | 1.30e-08 | 257 | 84 | 9 | 16335952 | ||
| Pubmed | 1.36e-08 | 3 | 84 | 3 | 19284629 | ||
| Pubmed | 1.36e-08 | 3 | 84 | 3 | 33895391 | ||
| Pubmed | 1.36e-08 | 3 | 84 | 3 | 23859570 | ||
| Pubmed | 1.36e-08 | 3 | 84 | 3 | 12610651 | ||
| Pubmed | 1.36e-08 | 3 | 84 | 3 | 19699781 | ||
| Pubmed | 1.36e-08 | 3 | 84 | 3 | 18784617 | ||
| Pubmed | 1.36e-08 | 3 | 84 | 3 | 17544618 | ||
| Pubmed | 1.36e-08 | 3 | 84 | 3 | 14973256 | ||
| Pubmed | 5.43e-08 | 4 | 84 | 3 | 17537961 | ||
| Pubmed | 5.43e-08 | 4 | 84 | 3 | 22260870 | ||
| Pubmed | 5.43e-08 | 4 | 84 | 3 | 35801810 | ||
| Pubmed | 5.43e-08 | 4 | 84 | 3 | 35031483 | ||
| Pubmed | 5.43e-08 | 4 | 84 | 3 | 29578003 | ||
| Pubmed | Use of recombinant inbred strains for studying genetic determinants of responses to alcohol. | 5.43e-08 | 4 | 84 | 3 | 8974318 | |
| Pubmed | 1.35e-07 | 5 | 84 | 3 | 1679748 | ||
| Pubmed | 1.35e-07 | 5 | 84 | 3 | 24337656 | ||
| Pubmed | Androgen-dependent hereditary mouse keratoconus: linkage to an MHC region. | 2.70e-07 | 6 | 84 | 3 | 11773012 | |
| Pubmed | Pain without nociceptors? Nav1.7-independent pain mechanisms. | 4.72e-07 | 7 | 84 | 3 | 24440715 | |
| Pubmed | 7.54e-07 | 8 | 84 | 3 | 25101983 | ||
| Pubmed | 7.54e-07 | 8 | 84 | 3 | 11784029 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 7.54e-07 | 8 | 84 | 3 | 19033399 | |
| Pubmed | Molecular genetics of the human MHC complement gene cluster. | 7.54e-07 | 8 | 84 | 3 | 10072631 | |
| Pubmed | Genetic mapping of the peripheral sodium channel genes, Scn9a and Scn10a, in the mouse. | 1.13e-06 | 9 | 84 | 3 | 8854872 | |
| Pubmed | 1.13e-06 | 9 | 84 | 3 | 15746173 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 1.15e-06 | 139 | 84 | 6 | 16985003 | |
| Pubmed | Organizations and gene duplications of the human and mouse MHC complement gene clusters. | 2.21e-06 | 11 | 84 | 3 | 10686478 | |
| Pubmed | 2.94e-06 | 12 | 84 | 3 | 19095005 | ||
| Pubmed | Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice. | 2.94e-06 | 12 | 84 | 3 | 30175250 | |
| Pubmed | 2.94e-06 | 12 | 84 | 3 | 8169823 | ||
| Pubmed | 3.99e-06 | 44 | 84 | 4 | 31273033 | ||
| Pubmed | MED12 regulates a transcriptional network of calcium-handling genes in the heart. | 4.85e-06 | 14 | 84 | 3 | 28724790 | |
| Pubmed | Screening for N-glycosylated proteins by liquid chromatography mass spectrometry. | 5.22e-06 | 47 | 84 | 4 | 14760718 | |
| Pubmed | 5.31e-06 | 181 | 84 | 6 | 37372979 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 5.76e-06 | 2 | 84 | 2 | 16565498 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 15998580 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 19062096 | ||
| Pubmed | cAMP-specific phosphodiesterases 8A and 8B, essential regulators of Leydig cell steroidogenesis. | 5.76e-06 | 2 | 84 | 2 | 22232524 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 20346423 | ||
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 5.76e-06 | 2 | 84 | 2 | 19933335 | |
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 5.76e-06 | 2 | 84 | 2 | 2459207 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 5.76e-06 | 2 | 84 | 2 | 17645767 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 12207352 | ||
| Pubmed | Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice. | 5.76e-06 | 2 | 84 | 2 | 10827969 | |
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 5.76e-06 | 2 | 84 | 2 | 27758680 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 22387014 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 19694741 | ||
| Pubmed | Genomic structures of SCN2A and SCN3A - candidate genes for deafness at the DFNA16 locus. | 5.76e-06 | 2 | 84 | 2 | 11245985 | |
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 5.76e-06 | 2 | 84 | 2 | 23749435 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 23918728 | ||
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 5.76e-06 | 2 | 84 | 2 | 3037333 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 11726230 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 4216347 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 21187369 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 25265377 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 27794518 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 17259277 | ||
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 5.76e-06 | 2 | 84 | 2 | 6950384 | |
| Pubmed | Differential expression of two sodium channel subtypes in human brain. | 5.76e-06 | 2 | 84 | 2 | 1317301 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 8660986 | ||
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 5.76e-06 | 2 | 84 | 2 | 8428773 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 28431990 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 16839343 | ||
| Pubmed | Duplication of the sodium channel gene cluster on 2q24 in children with early onset epilepsy. | 5.76e-06 | 2 | 84 | 2 | 23016767 | |
| Pubmed | Ryanodine receptor oligomeric interaction: identification of a putative binding region. | 5.76e-06 | 2 | 84 | 2 | 14722100 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 24638111 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 25903134 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 27153334 | ||
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 5.76e-06 | 2 | 84 | 2 | 21345967 | |
| Pubmed | Electrophysiological Differences between the Same Pore Region Mutation in SCN1A and SCN3A. | 5.76e-06 | 2 | 84 | 2 | 24990319 | |
| Pubmed | Na+ current properties in islet α- and β-cells reflect cell-specific Scn3a and Scn9a expression. | 5.76e-06 | 2 | 84 | 2 | 25172946 | |
| Pubmed | Structural and functional interactions within ryanodine receptor. | 5.76e-06 | 2 | 84 | 2 | 26009179 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 31439038 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 36111846 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 32899693 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 2572548 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 2302180 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 22151770 | ||
| Pubmed | C4d-positive chronic rejection: a frequent entity with a poor outcome. | 5.76e-06 | 2 | 84 | 2 | 18091514 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 29080553 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 6589636 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 5.76e-06 | 2 | 84 | 2 | 25339671 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 17728371 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 6149580 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 6149581 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 12115608 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 3542363 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 2387317 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 16908004 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 7365238 | ||
| Pubmed | Severe epilepsy, retardation, and dysmorphic features with a 2q deletion including SCN1A and SCN2A. | 5.76e-06 | 2 | 84 | 2 | 15249644 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 7391573 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 17971360 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 27690330 | ||
| Pubmed | Clinical features of patients with homozygous complement C4A or C4B deficiency. | 5.76e-06 | 2 | 84 | 2 | 29928053 | |
| Interaction | CACNA1D interactions | 3.94e-08 | 24 | 82 | 5 | int:CACNA1D | |
| Cytoband | 2q24.3 | 3.25e-06 | 16 | 84 | 3 | 2q24.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q24 | 3.88e-06 | 127 | 84 | 5 | chr2q24 | |
| Cytoband | 2q24 | 1.80e-04 | 11 | 84 | 2 | 2q24 | |
| Cytoband | 18q12.1 | 1.04e-03 | 26 | 84 | 2 | 18q12.1 | |
| Cytoband | Xp21.1 | 1.79e-03 | 34 | 84 | 2 | Xp21.1 | |
| Cytoband | 9q34 | 4.45e-03 | 54 | 84 | 2 | 9q34 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 5.45e-11 | 9 | 63 | 5 | 1203 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 3.58e-05 | 3 | 63 | 2 | 287 | |
| GeneFamily | Protein phosphatase 2 modulatory subunits | 1.19e-04 | 5 | 63 | 2 | 1265 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 4.23e-04 | 9 | 63 | 2 | 1234 | |
| GeneFamily | Apolipoprotein B mRNA editing enzyme catalytic subunits | 7.71e-04 | 12 | 63 | 2 | 406 | |
| GeneFamily | C2 domain containing|Calpains | 1.22e-03 | 15 | 63 | 2 | 975 | |
| GeneFamily | Polypeptide N-acetylgalactosaminyltransferases | 2.18e-03 | 20 | 63 | 2 | 433 | |
| GeneFamily | Phosphodiesterases | 3.14e-03 | 24 | 63 | 2 | 681 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 3.35e-03 | 718 | 63 | 8 | 28 | |
| GeneFamily | Complement system|Sushi domain containing | 6.98e-03 | 36 | 63 | 2 | 492 | |
| GeneFamily | Glycosyltransferase family 6|Blood group antigens | 7.36e-03 | 37 | 63 | 2 | 454 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.76e-07 | 154 | 84 | 6 | ba55a63cfa5e0fb9dfec794f80078a2f0d03d0ad | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.20e-07 | 169 | 84 | 6 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.62e-06 | 190 | 84 | 6 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.16e-06 | 145 | 84 | 5 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | droplet-Liver-Npc-21m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.98e-06 | 71 | 84 | 4 | cf4c8715c2bd77fc86e45cc01bcc7aa6044e091d | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD8-Trm_gut_CD8|blood / Manually curated celltypes from each tissue | 1.03e-05 | 152 | 84 | 5 | 1fea735321da6db6d2cd3f83d2f7fac72d44904d | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-05 | 170 | 84 | 5 | 71c52fadecc6b4bfe98692b266adaa1406f6d56d | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.86e-05 | 172 | 84 | 5 | 422d311bba2dd5d8bece4e96ee8c86e78086b62d | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-plasmacytoid_dendritic_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.86e-05 | 172 | 84 | 5 | 1abb6fbb28c8aff384540493d0f70eeacaa751f4 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.97e-05 | 174 | 84 | 5 | 1d157f7a919c8246e83d8060d2a0017c6c781ef3 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.20e-05 | 178 | 84 | 5 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.51e-05 | 183 | 84 | 5 | 4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.51e-05 | 183 | 84 | 5 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-05 | 184 | 84 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 2.57e-05 | 184 | 84 | 5 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-05 | 184 | 84 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-05 | 184 | 84 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-05 | 185 | 84 | 5 | c083a4974590b9ed3ecafedd3e9cdebc5047fe39 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.71e-05 | 186 | 84 | 5 | 40070d9cd20188ba49b32acfca9bc16256b38bf5 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.71e-05 | 186 | 84 | 5 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-05 | 187 | 84 | 5 | 7b2cd0c618ed081223343f3bec2244c8723c9a31 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.78e-05 | 187 | 84 | 5 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-05 | 188 | 84 | 5 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 2.85e-05 | 188 | 84 | 5 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 2.93e-05 | 189 | 84 | 5 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| ToppCell | facs-Lung-18m-Mesenchymal|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.93e-05 | 189 | 84 | 5 | bdf8db938aa0863c4fed6fa99dcffd63c8c20c31 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.93e-05 | 189 | 84 | 5 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.93e-05 | 189 | 84 | 5 | 40cbd679dc0548bf5207e1b033c0597886ad6fe1 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.08e-05 | 191 | 84 | 5 | 44a9a6768084dafc641ad455b65862bfd4cc0cb9 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.08e-05 | 191 | 84 | 5 | 48823a97c38263f2c6e58348214f5b62773a6368 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 3.08e-05 | 191 | 84 | 5 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.08e-05 | 191 | 84 | 5 | 0eedc66e967b1837ce2c14f8c14b3c1eba868c76 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.23e-05 | 193 | 84 | 5 | ec81c1afdae2e0433a22c8c1fa1c6232526ff7e7 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.23e-05 | 193 | 84 | 5 | 040f6bb42aa41d0921371fdda1cc0912c4fe1930 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.23e-05 | 193 | 84 | 5 | e468287c8b30c56d1de65e8347ade233ba6cf584 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.23e-05 | 193 | 84 | 5 | 30481fb01c7acf85beae10213f038da86bed6777 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 3.32e-05 | 194 | 84 | 5 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Club|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.57e-05 | 197 | 84 | 5 | 01e9505d947e5a5f005d1eab96301f84fc194809 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 3.57e-05 | 197 | 84 | 5 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.65e-05 | 198 | 84 | 5 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | LAM-Endothelial-LymEndo|Endothelial / Condition, Lineage and Cell class | 3.65e-05 | 198 | 84 | 5 | ba64b1c95dfaa995045239d412e725596f6c482e | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.65e-05 | 198 | 84 | 5 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.65e-05 | 198 | 84 | 5 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Lymphatic|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 3.74e-05 | 199 | 84 | 5 | 88f33b8dcd837abfa1d12c28719e073a7da6e979 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.74e-05 | 199 | 84 | 5 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Lymphatic|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.74e-05 | 199 | 84 | 5 | 64b19aff72e2a109cb5857cb248bd4712dd49b43 | |
| ToppCell | Sepsis-Bac-SEP-Myeloid-tDC|Bac-SEP / Disease, condition lineage and cell class | 3.74e-05 | 199 | 84 | 5 | a2be40d367338d32348a6906c8475aa3b544a0f7 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Lymphatic-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.74e-05 | 199 | 84 | 5 | 2b9e1e069b36b3a61cc3e384f4523687b0e03905 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast-(8)_Fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.74e-05 | 199 | 84 | 5 | 56d72da6a5fab9cbb2975fe6f87a631debaba6a8 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.83e-05 | 200 | 84 | 5 | fc28f71ca1cd0fdae66009ae5afe175d22f2bd8c | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.83e-05 | 200 | 84 | 5 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.83e-05 | 200 | 84 | 5 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.83e-05 | 200 | 84 | 5 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.83e-05 | 200 | 84 | 5 | acc771a902cf2f060c3eb9aedb72a256f5778a6c | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-AT2-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 3.83e-05 | 200 | 84 | 5 | ceb613ac6cdf0e3e6bb3f04d89034e18a524cefb | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.83e-05 | 200 | 84 | 5 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.83e-05 | 200 | 84 | 5 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.83e-05 | 200 | 84 | 5 | eb44d1f80ecaac3a022cd04ab16dc36151e45488 | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.83e-05 | 200 | 84 | 5 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_ALM_Sla|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.14e-04 | 132 | 84 | 4 | ddebc0b233fdbb73ceb70187945bbed8fd273f2a | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Tpbg_(eccentric_SPN,_dSPN-like_markers)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.15e-04 | 50 | 84 | 3 | 9a54cd5a55ef53f7a8b43fe76c4e0e47b44b8c71 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Tpbg_(eccentric_SPN,_dSPN-like_markers)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.15e-04 | 50 | 84 | 3 | cd5e2a8f4fa4a31d0c7a74d5826485e42b3908f7 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.17e-04 | 133 | 84 | 4 | 5bf5e654653e2c340891f51e3f2a30441b7b6b2b | |
| ToppCell | frontal_cortex-Non-neuronal-oligodendrocyte-Oligo-Oligo_Serpinb1a|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.31e-04 | 137 | 84 | 4 | ca8fdbe66a854e6283b22179ec9359ea9e86cd8e | |
| ToppCell | Hippocampus-Macroglia-OLIGODENDROCYTE|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.31e-04 | 137 | 84 | 4 | 5e97480f014f1d9267e8126f1d0e58acd22f36aa | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-Oligo_Serpinb1a|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.39e-04 | 139 | 84 | 4 | 789edd3c98e7c5c1cc402c780fded9a9dfd1dfb8 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Epi-like-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-04 | 142 | 84 | 4 | d52da766e031f7409eb5a7a9fa88f48e14a79d8b | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Epi-like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-04 | 142 | 84 | 4 | a05b320cf182b2aaf18df7c40045dc65b659bf20 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-13|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.59e-04 | 144 | 84 | 4 | b2a9f3b5dd46d27689467f4a5fd717cd5827821f | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.72e-04 | 147 | 84 | 4 | 3ed5b020ce1f1277917d79ef1f7da53fa474e8db | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-04 | 152 | 84 | 4 | 82a493ffb2f1704cd6f68a82d970fe12f537d20e | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.01e-04 | 153 | 84 | 4 | 991782d111d66e25b40319d4e6dea40f2c2c0805 | |
| ToppCell | facs-Liver|facs / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 158 | 84 | 4 | ea7db6bd9742153ceb6e444892a6d1df9c7fcc96 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.33e-04 | 159 | 84 | 4 | 1472536eea61d4f13033efe42f128bae1614fa74 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.33e-04 | 159 | 84 | 4 | f7bccfeffa737f151417bf52ea45111b0957bce9 | |
| ToppCell | severe_COVID-19-pDC|severe_COVID-19 / disease group, cell group and cell class (v2) | 2.33e-04 | 159 | 84 | 4 | ea5088d27e42b8850455764d53b757ea8d8f14bc | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.50e-04 | 162 | 84 | 4 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-04 | 162 | 84 | 4 | de0fde4310a56dc96bfc134c44d104993526d9bc | |
| ToppCell | Bac-SEP-Myeloid-tDC|Bac-SEP / Disease, Lineage and Cell Type | 2.68e-04 | 165 | 84 | 4 | 8728f927502e56f2768b4224e9111939d3d7815a | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-04 | 165 | 84 | 4 | f80665b75d43f1bf6919d59fc762e7e0bac653f2 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-Granular_Neuron_CB_Gabra6|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-04 | 166 | 84 | 4 | ec7bd549bda5f18aca8aebce5ba479a81abbbeda | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-04 | 166 | 84 | 4 | c215c4aede38d355d35fd26cd7ef2c19efecd0e6 | |
| ToppCell | VE-Treg-exh_CD4|VE / Condition, Cell_class and T cell subcluster | 2.80e-04 | 167 | 84 | 4 | 1036ac1ef9440612500137af9d1929672b077e4d | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.87e-04 | 168 | 84 | 4 | 99148986aa5628f67d85258c171b254be77a071c | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 2.87e-04 | 168 | 84 | 4 | 968405ea56f7d001ef83ff9274610923c3b2d55d | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_B0|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.93e-04 | 169 | 84 | 4 | 89b5452e0d8d058648a1d2659f1611fd6aebc6b6 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-04 | 169 | 84 | 4 | bb43abad2c049b7f4d307737347290e01b3339a3 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-04 | 169 | 84 | 4 | 5f18e3f40a5b1b167903f37516ec8181e889c7c5 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-04 | 169 | 84 | 4 | 8bfa2d3bb541d02f55d7c95b8fd156c8403befca | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-04 | 172 | 84 | 4 | 7fb31ccbcd0204c3612986a6bc20d57ed6825e9c | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-04 | 172 | 84 | 4 | 2a4614b3d25e8c6b095e6992d8ca35371dcdb5e1 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-04 | 173 | 84 | 4 | ca3d2a9562734f76127e3e7d54c10b63e95141bb | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-04 | 173 | 84 | 4 | 19a9e10885173d7712996be8660a3a5a7a9aa39f | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 3.21e-04 | 173 | 84 | 4 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.21e-04 | 173 | 84 | 4 | 7e2149205e119cec4f5099c83c85d1e13470137a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.35e-04 | 175 | 84 | 4 | 9a96a946db731ba24c9be34bedebf1f4a1372b9e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.35e-04 | 175 | 84 | 4 | 54c1f080195ad8392a095e83b56a4b54073d4c0d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.35e-04 | 175 | 84 | 4 | 2b51406a2c2daa13ab4ed283ede038cd11d9e641 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.50e-04 | 177 | 84 | 4 | a235ff4f37a7622216526191efc4832fb8ed6957 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-04 | 177 | 84 | 4 | 1dc69c661e70e7e22bd9d7cf953eb638da9fd43c | |
| Drug | lamotrigine | 2.06e-07 | 116 | 82 | 7 | CID000003878 | |
| Drug | Zonisamide | 3.59e-07 | 17 | 82 | 4 | DB00909 | |
| Drug | LMWH | LIPM HS2ST1 LRP1 CHPF2 C4A APOA4 ADAMTS13 FGFR2 TNXB F8 RYR1 RYR2 IMPG2 | 6.78e-07 | 663 | 82 | 13 | CID000000772 |
| Drug | APETx1, Anthopleura elegantissima | 8.94e-07 | 6 | 82 | 3 | ctd:C475726 | |
| Drug | fenpropathrin | 8.94e-07 | 6 | 82 | 3 | ctd:C044267 | |
| Drug | phenytoin | 1.25e-06 | 219 | 82 | 8 | CID000001775 | |
| Drug | dihydrochloride | 1.74e-06 | 159 | 82 | 7 | CID000070978 | |
| Drug | 2,3,5,6-tetrafluoro-4-methylbenzyl (Z)-(1RS)-cis-3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate | 2.49e-06 | 8 | 82 | 3 | ctd:C489827 | |
| Drug | nefopam | 2.57e-06 | 27 | 82 | 4 | CID000004450 | |
| Drug | arabinosyladenine | DPP4 PTPA IGF2R PDE8A PDE8B CAPN3 C4A ATP11A ATP2A2 TNXB F8 RYR1 RYR2 | 3.17e-06 | 762 | 82 | 13 | CID000000191 |
| Drug | olanzapine | 5.01e-06 | 121 | 82 | 6 | ctd:C076029 | |
| Drug | flecainide | 5.79e-06 | 71 | 82 | 5 | CID000003355 | |
| Drug | 1, 3-diallylurea | 7.10e-06 | 74 | 82 | 5 | CID000074537 | |
| Drug | benzocaine | 9.43e-06 | 37 | 82 | 4 | CID000002337 | |
| Drug | Tetracaine | 9.68e-06 | 12 | 82 | 3 | ctd:D013748 | |
| Drug | 4-hydroxybutyl acrylate | 1.28e-05 | 2 | 82 | 2 | CID000075588 | |
| Drug | Sodium | 1.32e-05 | 84 | 82 | 5 | ctd:D012964 | |
| Drug | procaine | 1.92e-05 | 153 | 82 | 6 | CID000004914 | |
| Drug | lidocaine | 2.47e-05 | 160 | 82 | 6 | CID000003676 | |
| Drug | AC1L9KQO | 2.93e-05 | 49 | 82 | 4 | CID000447335 | |
| Drug | indo-1 | 2.94e-05 | 99 | 82 | 5 | CID000105060 | |
| Drug | isradipine | 3.08e-05 | 100 | 82 | 5 | CID000003784 | |
| Drug | gabapentin | 3.36e-05 | 169 | 82 | 6 | CID000003446 | |
| Drug | Scorpion Venoms | 3.53e-05 | 18 | 82 | 3 | ctd:D012604 | |
| Drug | cis-diammineplatinum(II | 3.84e-05 | 3 | 82 | 2 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 3.84e-05 | 3 | 82 | 2 | CID002750949 | |
| Drug | 8N3-cADPR | 3.84e-05 | 3 | 82 | 2 | CID000127713 | |
| Drug | N-(2-methyl-3-(4-(4-(4-(trifluoromethoxy)benzyloxy)piperidin-1-yl)-1,3,5-triazin-2-ylamino)phenyl)acetamide | 3.84e-05 | 3 | 82 | 2 | ctd:C561228 | |
| Drug | 2-aminothiophenol | 3.84e-05 | 3 | 82 | 2 | ctd:C005464 | |
| Drug | aminodantrolene | 3.84e-05 | 3 | 82 | 2 | CID009570289 | |
| Drug | E 4021 | 3.84e-05 | 3 | 82 | 2 | ctd:C091517 | |
| Drug | 2-hydroxycarbazole | 3.84e-05 | 3 | 82 | 2 | CID000093551 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 3.84e-05 | 3 | 82 | 2 | CID005748312 | |
| Drug | riluzole | 3.96e-05 | 174 | 82 | 6 | CID000005070 | |
| Drug | AC1L380G | 4.19e-05 | 19 | 82 | 3 | CID000084698 | |
| Drug | diprafenone | 4.19e-05 | 19 | 82 | 3 | CID000071249 | |
| Drug | NSC7524 | 5.08e-05 | 182 | 82 | 6 | CID000005657 | |
| Drug | indo-1/AM | 5.71e-05 | 21 | 82 | 3 | CID000123918 | |
| Drug | NF T | 6.46e-05 | 190 | 82 | 6 | CID006436102 | |
| Drug | propofol | 6.65e-05 | 191 | 82 | 6 | CID000004943 | |
| Drug | Phenytoin | 7.45e-05 | 385 | 82 | 8 | ctd:D010672 | |
| Drug | Lidocaine | 7.65e-05 | 4 | 82 | 2 | DB00281 | |
| Drug | PCB74 | 7.65e-05 | 4 | 82 | 2 | CID000036218 | |
| Drug | APETx2 protein, Anthopleura elegantissima | 7.65e-05 | 4 | 82 | 2 | ctd:C501880 | |
| Drug | Deladroxone | 7.65e-05 | 4 | 82 | 2 | CID000032327 | |
| Drug | 148504-47-6 | 7.65e-05 | 4 | 82 | 2 | CID006444275 | |
| Drug | SC 38249 | 7.65e-05 | 4 | 82 | 2 | CID000134834 | |
| Drug | AC1L1U7A | 7.65e-05 | 4 | 82 | 2 | CID000035682 | |
| Drug | ethacizine | 7.65e-05 | 4 | 82 | 2 | CID000107841 | |
| Drug | Clorocruoro Hem | 8.30e-05 | 123 | 82 | 5 | CID003518809 | |
| Drug | Austricine [10180-88-8]; Down 200; 14.2uM; HL60; HT_HG-U133A | 8.57e-05 | 200 | 82 | 6 | 2157_DN | |
| Drug | PMEI | 8.63e-05 | 24 | 82 | 3 | CID000451928 | |
| Drug | saxitoxin | 8.95e-05 | 65 | 82 | 4 | CID000037165 | |
| Drug | AC1L1CQC | 8.95e-05 | 65 | 82 | 4 | CID000002012 | |
| Drug | bepridil | 9.30e-05 | 126 | 82 | 5 | CID000002351 | |
| Drug | AC1L320U | 9.78e-05 | 25 | 82 | 3 | CID000133020 | |
| Drug | AC1L1KOK | 9.78e-05 | 25 | 82 | 3 | CID000005588 | |
| Drug | AC1NT1AF | 9.78e-05 | 25 | 82 | 3 | CID005322157 | |
| Drug | Multicide | 9.78e-05 | 25 | 82 | 3 | CID000024365 | |
| Drug | dibucaine | 1.07e-04 | 68 | 82 | 4 | CID000003025 | |
| Drug | Pirmenolum | 1.10e-04 | 26 | 82 | 3 | CID000004853 | |
| Drug | methyl palmoxirate | 1.10e-04 | 26 | 82 | 3 | CID000068593 | |
| Drug | AC1L1IZE | 1.12e-04 | 131 | 82 | 5 | CID000004799 | |
| Drug | GBR 12909 | 1.13e-04 | 69 | 82 | 4 | CID000003455 | |
| Drug | PbTx-1 | 1.24e-04 | 27 | 82 | 3 | CID006437089 | |
| Drug | AC1L1MOZ | 1.24e-04 | 27 | 82 | 3 | CID000031958 | |
| Drug | Km 201 | 1.27e-04 | 5 | 82 | 2 | CID000089125 | |
| Drug | A 68930 | 1.27e-04 | 5 | 82 | 2 | ctd:C065380 | |
| Drug | sodium | DPP4 SCN2A SCN3A SCN9A SCN10A CP ATP11A SERPINA6 ATP2A2 RYR1 RYR2 GABRA6 | 1.38e-04 | 944 | 82 | 12 | CID000000923 |
| Drug | paraben | 1.38e-04 | 28 | 82 | 3 | CID000007175 | |
| Drug | isoproterenol | 1.43e-04 | 669 | 82 | 10 | CID000003779 | |
| Drug | dermatan sulfate | 1.44e-04 | 220 | 82 | 6 | CID000032756 | |
| Drug | cyfluthrin | 1.54e-04 | 29 | 82 | 3 | ctd:C052570 | |
| Drug | cantharidic acid | 1.54e-04 | 29 | 82 | 3 | CID000002544 | |
| Drug | Bicuculline | 1.54e-04 | 29 | 82 | 3 | ctd:D001640 | |
| Drug | diphenhydramine | 1.56e-04 | 75 | 82 | 4 | CID000003100 | |
| Drug | LOPAC | 1.70e-04 | 30 | 82 | 3 | CID000062696 | |
| Drug | tocainide | 1.70e-04 | 30 | 82 | 3 | CID000038945 | |
| Drug | M-HN | 1.88e-04 | 31 | 82 | 3 | CID000015450 | |
| Drug | dinophysistoxin-1 | 1.88e-04 | 31 | 82 | 3 | CID006437058 | |
| Drug | chloro-m-cresol | 1.90e-04 | 6 | 82 | 2 | CID000012008 | |
| Drug | MBED | 1.90e-04 | 6 | 82 | 2 | CID000129958 | |
| Drug | AC1O528X | 1.90e-04 | 6 | 82 | 2 | CID006475857 | |
| Drug | estradiol enanthate | 1.90e-04 | 6 | 82 | 2 | CID000021070 | |
| Drug | NSC114784 | 1.90e-04 | 6 | 82 | 2 | CID000419425 | |
| Drug | NSC93767 | 2.07e-04 | 32 | 82 | 3 | CID000005658 | |
| Drug | bupropion | 2.11e-04 | 81 | 82 | 4 | CID000000444 | |
| Drug | NSC-270916 | 2.21e-04 | 82 | 82 | 4 | CID000002949 | |
| Drug | Tacrolimus | 2.23e-04 | 339 | 82 | 7 | ctd:D016559 | |
| Drug | 5-hydroxypropafenone | 2.49e-04 | 34 | 82 | 3 | CID000107927 | |
| Drug | forskolin from Coleus forskohlii | PTPN5 PTPA PDE8A PDE8B SCN3A SCN9A SCN10A HRH1 FGFR2 RYR1 RYR2 GABRA6 | 2.64e-04 | 1013 | 82 | 12 | CID000003413 |
| Drug | Coagulation Factor IX | 2.66e-04 | 7 | 82 | 2 | DB00100 | |
| Drug | Orphenadrine | 2.66e-04 | 7 | 82 | 2 | DB01173 | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 2.66e-04 | 7 | 82 | 2 | CID009547999 | |
| Drug | Azumoleno | 2.66e-04 | 7 | 82 | 2 | CID000056259 | |
| Drug | Br2BAPTA | 2.66e-04 | 7 | 82 | 2 | CID003081001 | |
| Drug | CHAPS detergent | 2.68e-04 | 158 | 82 | 5 | CID000107670 | |
| Drug | endothall | 2.95e-04 | 36 | 82 | 3 | CID000003225 | |
| Drug | mag-fura-2 | 3.20e-04 | 37 | 82 | 3 | CID000123839 | |
| Drug | Leu-Glu | 3.20e-04 | 37 | 82 | 3 | CID000484686 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 3.02e-11 | 10 | 79 | 5 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 3.02e-11 | 10 | 79 | 5 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 9.44e-11 | 12 | 79 | 5 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 5.93e-09 | 9 | 79 | 4 | C3502809 | |
| Disease | anxiety disorder (implicated_via_orthology) | 3.36e-07 | 22 | 79 | 4 | DOID:2030 (implicated_via_orthology) | |
| Disease | Congenital Pain Insensitivity | 6.41e-07 | 7 | 79 | 3 | C0002768 | |
| Disease | epilepsy (implicated_via_orthology) | 5.16e-06 | 163 | 79 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | Infantile Severe Myoclonic Epilepsy | 5.18e-06 | 13 | 79 | 3 | C0751122 | |
| Disease | Early Infantile Epileptic Encephalopathy 6 | 7.08e-06 | 2 | 79 | 2 | C4551549 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 2.12e-05 | 3 | 79 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 2.12e-05 | 3 | 79 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | Primary Erythermalgia | 2.12e-05 | 3 | 79 | 2 | C0014805 | |
| Disease | PAROXYSMAL EXTREME PAIN DISORDER | 2.12e-05 | 3 | 79 | 2 | C1833661 | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 6.45e-05 | 80 | 79 | 4 | DOID:6432 (biomarker_via_orthology) | |
| Disease | Seizure, Febrile, Simple | 1.47e-04 | 7 | 79 | 2 | C0149886 | |
| Disease | Seizure, Febrile, Complex | 1.47e-04 | 7 | 79 | 2 | C0751057 | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 5 | 1.47e-04 | 7 | 79 | 2 | C0020075 | |
| Disease | Early Childhood Epilepsy, Myoclonic | 1.96e-04 | 8 | 79 | 2 | C0393695 | |
| Disease | Idiopathic Myoclonic Epilepsy | 1.96e-04 | 8 | 79 | 2 | C0338478 | |
| Disease | Symptomatic Myoclonic Epilepsy | 1.96e-04 | 8 | 79 | 2 | C0338479 | |
| Disease | Benign Infantile Myoclonic Epilepsy | 1.96e-04 | 8 | 79 | 2 | C0751120 | |
| Disease | Myoclonic Encephalopathy | 1.96e-04 | 8 | 79 | 2 | C0438414 | |
| Disease | Myoclonic Absence Epilepsy | 1.96e-04 | 8 | 79 | 2 | C0393703 | |
| Disease | Pruritus | 1.96e-04 | 8 | 79 | 2 | C0033774 | |
| Disease | Febrile Convulsions | 2.52e-04 | 9 | 79 | 2 | C0009952 | |
| Disease | Myoclonic Epilepsy | 2.52e-04 | 9 | 79 | 2 | C0014550 | |
| Disease | postburn hypertrophic scarring severity measurement | 3.14e-04 | 10 | 79 | 2 | EFO_0007747 | |
| Disease | Epilepsy, Myoclonic, Infantile | 3.14e-04 | 10 | 79 | 2 | C0917800 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 3.17e-04 | 220 | 79 | 5 | EFO_0004529, EFO_0008317 | |
| Disease | Diabetic Cardiomyopathies | 3.83e-04 | 11 | 79 | 2 | C0853897 | |
| Disease | Myoclonic Astatic Epilepsy | 3.83e-04 | 11 | 79 | 2 | C0393702 | |
| Disease | Congenital muscular dystrophy | 4.59e-04 | 12 | 79 | 2 | cv:C0699743 | |
| Disease | Skin Abnormalities | 5.42e-04 | 13 | 79 | 2 | C0037268 | |
| Disease | Schizophrenia | 5.84e-04 | 883 | 79 | 9 | C0036341 | |
| Disease | Mental Depression | 6.10e-04 | 254 | 79 | 5 | C0011570 | |
| Disease | Autosomal recessive limb-girdle muscular dystrophy | 6.31e-04 | 14 | 79 | 2 | cv:C2931907 | |
| Disease | very low density lipoprotein cholesterol measurement | 6.77e-04 | 260 | 79 | 5 | EFO_0008317 | |
| Disease | MMR-related febrile seizures | 7.27e-04 | 15 | 79 | 2 | EFO_0006519 | |
| Disease | Neuralgia, Supraorbital | 8.29e-04 | 16 | 79 | 2 | C0038870 | |
| Disease | Neuralgia | 8.29e-04 | 16 | 79 | 2 | C0027796 | |
| Disease | Neuralgia, Atypical | 8.29e-04 | 16 | 79 | 2 | C0234247 | |
| Disease | Neuralgia, Stump | 8.29e-04 | 16 | 79 | 2 | C0234249 | |
| Disease | Neuralgia, Iliohypogastric Nerve | 8.29e-04 | 16 | 79 | 2 | C0423712 | |
| Disease | Neuralgia, Perineal | 8.29e-04 | 16 | 79 | 2 | C0423711 | |
| Disease | Paroxysmal Nerve Pain | 8.29e-04 | 16 | 79 | 2 | C0751373 | |
| Disease | Nerve Pain | 8.29e-04 | 16 | 79 | 2 | C0751372 | |
| Disease | Neuralgia, Ilioinguinal | 8.29e-04 | 16 | 79 | 2 | C0751371 | |
| Disease | Neuralgia, Vidian | 8.29e-04 | 16 | 79 | 2 | C0042656 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 8.29e-04 | 16 | 79 | 2 | C0393706 | |
| Disease | heart disease (biomarker_via_orthology) | 9.38e-04 | 17 | 79 | 2 | DOID:114 (biomarker_via_orthology) | |
| Disease | muscular dystrophy (is_implicated_in) | 9.38e-04 | 17 | 79 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | Multiple congenital anomalies | 9.38e-04 | 17 | 79 | 2 | C0000772 | |
| Disease | Limb Deformities, Congenital | 9.38e-04 | 17 | 79 | 2 | C0206762 | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 1.05e-03 | 18 | 79 | 2 | HP_0002373 | |
| Disease | Depressive disorder | 1.09e-03 | 289 | 79 | 5 | C0011581 | |
| Disease | Intrahepatic Cholangiocarcinoma | 1.88e-03 | 24 | 79 | 2 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 1.88e-03 | 24 | 79 | 2 | C3805278 | |
| Disease | Neurodevelopmental Disorders | 2.02e-03 | 93 | 79 | 3 | C1535926 | |
| Disease | Limb-girdle muscular dystrophy | 2.21e-03 | 26 | 79 | 2 | cv:C0686353 | |
| Disease | Cholangiocarcinoma | 2.21e-03 | 26 | 79 | 2 | C0206698 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FDEWNSLAVYVSMDN | 161 | Q8WYN0 | |
| FTDFDKYMTISDEWD | 266 | P55884 | |
| EMEEAELTSWYFVSS | 351 | P0C0L5 | |
| AQVSIMTYDEFEYCW | 331 | Q9UH17 | |
| TFGEIMVYWELSSEF | 4676 | Q8WXG9 | |
| MVYWELSSEFDITED | 4681 | Q8WXG9 | |
| TEWMTSIFIAQHEYD | 1526 | Q8WZ64 | |
| GEFWMTFEDVCRYFT | 321 | O15484 | |
| VLYWESESSQAEMEF | 1376 | Q76LX8 | |
| FFEAVSTQMEKWYER | 671 | Q9Y2G4 | |
| EVEDFIGVDSMYENW | 186 | Q8IWB1 | |
| FTYSEWMEEKIEDDF | 191 | P54829 | |
| WADLNAMNVYETTEF | 311 | Q7Z3E1 | |
| WSQYFESMEDVEVEN | 46 | Q9Y570 | |
| EVSADQVATVMWDYF | 21 | P06727 | |
| EFVVMFSVVDENFSW | 216 | P00450 | |
| EEFNTWVNNMYVFFV | 756 | P0C881 | |
| QNWVFVTEGMDDFRY | 46 | Q5HY64 | |
| ETWYFMVNVTDAISS | 116 | P21802 | |
| DKFWNMALTDVDETY | 191 | P83369 | |
| FANVFVSYMEEEQLW | 866 | Q8IV33 | |
| IDQDEFWAFSYDEMA | 146 | Q5VYY2 | |
| VQWEAVYMAIAFSVS | 131 | Q5VTL7 | |
| TVDYWSFGTMVFECI | 201 | O15111 | |
| MDMFSVSVFEDFIYW | 2096 | Q07954 | |
| FIDYFITDMFDAWDA | 781 | O60658 | |
| FIDYFITDMFDAWDA | 836 | O95263 | |
| QNWVFVTEGMDDFRY | 46 | Q8NA70 | |
| VGVDFQAMWYTDEDH | 726 | P27487 | |
| EYTMDVFFRQTWTDE | 76 | Q16445 | |
| IFDETKSWYFTENME | 1901 | P00451 | |
| MWEVFNEDGTVRYFI | 136 | Q9H4Q4 | |
| MSYADFVWFLISEED | 956 | Q06190 | |
| DEEFSANWMAVIFFI | 296 | Q02413 | |
| DAQWETDDTAEYEMV | 781 | Q13332 | |
| EVWMDEFKNFFYIIS | 371 | Q10472 | |
| IMDDEEFAYCWENFV | 146 | Q8IUX4 | |
| VIWVYSTDTNFSDMF | 1026 | P16615 | |
| DNEFATMWIERTTYT | 1476 | Q9H7D0 | |
| FFQSMEWDVGSDYAI | 251 | Q9H2C2 | |
| IDTIDWNTFEFYMQI | 256 | Q8N4A0 | |
| NASDFDQWEMETVYS | 96 | O43303 | |
| DVFFFYEETDHMWNG | 366 | O75072 | |
| MDCFEVYSPEADQWT | 46 | Q8IYD2 | |
| WVTVALMESDFEFEY | 2046 | Q5TBA9 | |
| ETDFYDVTWFKVMTA | 181 | P35367 | |
| VTEDGEFWMSYEDFI | 391 | P20807 | |
| YEGAFTWEFRDEMVN | 3361 | Q8IVF4 | |
| EWTVMDVVEYFTEAG | 461 | Q6SPF0 | |
| WYFEVMVDEVTPFLT | 661 | P21817 | |
| WYFEFETVTAGDMRV | 1101 | Q92736 | |
| YESEVLAMNFQDWAT | 151 | P08185 | |
| RMVWDSQASEHFFEY | 331 | Q9BWS9 | |
| EMEEAELTSWYFVSS | 351 | P0C0L4 | |
| YFAMVAENESEQESW | 176 | O14654 | |
| MFISAVEDCEYTFAW | 1486 | P11717 | |
| RLSTFYEDWSFVMDE | 141 | Q8TEQ0 | |
| YFCEVMFTAAWEFVV | 21 | Q8NBD8 | |
| EYWCSIAYFEMDVQV | 321 | Q13485 | |
| QSDIWKMENEFYEFA | 306 | Q7LGA3 | |
| MFYEVWEKFDPDATQ | 1781 | Q15858 | |
| SEDDFEMFYEVWEKF | 1786 | Q9NY46 | |
| DMEQITESSNYEWFD | 746 | Q9BZV3 | |
| TESSNYEWFDSEVSM | 751 | Q9BZV3 | |
| DTVVFYDSDWNPTMD | 2131 | Q6ZRS2 | |
| FFYFESVKEQEWSMA | 286 | Q01968 | |
| SEDDFEMFYEVWEKF | 1801 | P35498 | |
| FMYDSDSWAEDLIVS | 516 | O75969 | |
| FQFVVVEEQYEESFW | 176 | A0PK11 | |
| DWFFIMQDDTYVQAP | 176 | Q9P2E5 | |
| VSQWYELVVFTASME | 121 | O95476 | |
| SYFITWDEDMFDEET | 376 | P98196 | |
| FEDVAVFFTQEEWDY | 16 | O75820 | |
| MAFEDVAVYFSQEEW | 1 | O75467 | |
| VMFSDVSIDFSQEEW | 6 | Q8NA42 | |
| FEYRVSEMWNEVHEE | 66 | Q15257 | |
| LSEDDFDMFYETWEK | 1736 | Q9Y5Y9 | |
| TFEDMAVYFSEEEWQ | 206 | Q92670 | |
| WMVTEGEFDSFEIQY | 1901 | P22105 | |
| SEDDFEMFYEVWEKF | 1791 | Q99250 | |
| VMENEVDAFWCFASY | 466 | Q8TC07 | |
| VMFSDVSVDFSQEEW | 6 | Q969W8 | |
| GWSFCEYFMVQEELA | 216 | P48553 | |
| LSFEDVAMYFTREEW | 11 | Q5FWF6 | |
| MTFEDVAVYFSQEEW | 1 | Q6AW86 | |
| TFEDVSMDFSQEEWE | 46 | Q86TJ5 |